ArticleThe Journal of infection2022

Immunogenicity of a third dose of inactivated COVID-19 vaccine in people living with HIV-1, HBV, and tuberculosis during the Omicron variant epidemic: A cross-sectional study.

Yan Yan et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.